Drug policy has historically been shaped by political and social agendas rather than science, often targeting marginalized groups with disproportionate penalties. This has fueled stigma and harm toward people who use drugs and extended to professionals providing treatment. Outdated drug laws and international conventions have mischaracterized psychedelics as highly abusive with no medical value, further entrenching this bias.
As a result, many professionals lack access to unbiased education on psychedelic therapies. Stigmatization excludes psychedelics from mainstream learning, leading to misinformation and barriers to care. Individuals seeking guidance on psychedelic experiences or therapies often encounter stigma and discouragement, particularly those from marginalized communities facing systemic discrimination and increased law enforcement scrutiny.
Fluence is committed to creating a supportive and open learning environment where providers can explore the true risks and benefits of psychedelics. This approach promotes authentic, research-informed, patient-centered discussions, empowering providers to deliver high-quality care.
Thank you for being a part of our journey!
Sincerely,
Elizabeth and Ingmar, Fluence Co-Founders
